Insulin signaling in insulin-dysregulated Icelandic horses.

The research article is an investigation into the molecular mechanisms causing insulin dysregulation in Icelandic horses. The study found altered expressions and phosphorylation of proteins in key insulin signaling pathways in these horses, suggesting that insulin dysregulation may be a distinctive metabolic condition in this breed.

Research Objectives and Methodology

The researchers aimed to understand the molecular mechanisms causing insulin dysregulation in Icelandic horses. Twelve horses underwent two types of experiments: oral glucose challenge and intravenous insulin challenge. Their liver, muscle, and adipose tissue were biopsied under both challenges and under resting conditions. The research team then looked at the basal expression and phosphorylation extent of relevant proteins involved in insulin signaling in the various tissue samples collected.

Key Findings

• Out of twelve horses, six were identified as having insulin dysregulation. These horses showed significantly higher insulin levels.
• The glucose challenge resulted in higher insulin and glucose levels in horses with insulin dysregulation than those without it.
• Under both challenges, enhanced phosphorylation (activation) of the insulin receptor was observed in liver tissue but not in muscle or adipose tissue.
• Phosphorylation of a protein called protein kinase B increased in all tissues under glucose challenge and in muscle and adipose tissues under insulin challenge.
• Phosphorylation of another protein, adenosine monophosphate protein kinase α, reduced in all horses after glucose administration.
• All horses suffering from insulin dysregulation had higher amounts of another phosphorylated protein, the mechanistic target of rapamycin (mTOR), in their muscle tissue, regardless of stimulation.

Conclusions and Implications

The researchers concluded that although insulin signaling seems generally preserved in both insulin-dysregulated Icelandic horses and non-insulin-dysregulated ones, there were alterations observed in proteins downstream of the insulin receptor. Hence, insulin dysregulation could be considered a breed-specific metabolic condition in Icelandic horses. The increased levels of phosphorylated mTOR suggest that alterations in the mTOR signaling pathway could be a key factor in this condition.

Limitations

This study’s significant limitation is that it only incorporated older Icelandic horses. Consequently, the findings cannot be generalized to all horses since insulin dysregulation may be linked to age-related issues, such as equine metabolic syndrome or pituitary pars intermedia dysfunction.